Evidence map›Paper›PMID 32164353›Full record

ArticleMedicina (Kaunas, Lithuania)2020

Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family.

Ieva Sadzevičienė, Sonata Jarmalaitė, Justinas Besusparis, Olga Liaugaudienė, Jolita Asadauskienė, Birutė Brasiūnienė, Ilona Kulikienė, Rasa Sabaliauskaitė

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ieva SadzevičienėInstitute of Biosciences, Life Sciences Center, Vilnius University, Saulėtekio Avenue 7, LT-10222 Vilnius, Lithuania.
Sonata JarmalaitėLaboratory of Clinical Oncology, National Cancer Institute, Santariškių 1, LT-08406 Vilnius, Lithuania.
Justinas BesusparisFaculty of Medicine, Vilnius University, Čiurlionio, 21 LT-03101 Vilnius, Lithuania.
Olga LiaugaudienėDepartment of Consultative Polyclinic, National Cancer Institute, Santariškių 1, LT-08406 Vilnius, Lithuania.
Jolita AsadauskienėDepartment of Medical Oncology, National Cancer Institute, Santariškių 1, LT-08406 Vilnius, Lithuania.
Birutė BrasiūnienėDepartment of Medical Oncology, National Cancer Institute, Santariškių 1, LT-08406 Vilnius, Lithuania.
Ilona KulikienėLaboratory of Genetic Diagnostic, National Cancer Institute, Santariškių 1, LT-08406 Vilnius, Lithuania.
Rasa SabaliauskaitėLaboratory of Genetic Diagnostic, National Cancer Institute, Santariškių 1, LT-08406 Vilnius, Lithuania.
National Cancer Institute · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 10% of all breast cancer (BC) cases are familial and caused by inheritance of mutant

Indexed as

FamilyGenes, BRCA2Breast NeoplasmsFemaleHumansLithuaniaMiddle AgedMutationBRCA2BRCA testingbreast cancerc.3847_3848delGT

Identifiers

PMID32164353
PMCPMC7143304
OpenAlexW3011230583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.